TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3385897

Group type: EXPERIMENTAL
Intervention: Occupational work evaluation (n = 99)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual care (n = 102)
Number of subjects: 201
Study: 29518178

Group type: EXPERIMENTAL
Intervention: Delafloxacin 300 mg IV every 12 hours for 3 days followed by 450 mg oral delafloxacin
Number of subjects: 850

Group type: COMPARATOR
Intervention: Vancomycin 15 mg/kg IV with aztreonam for 5-14 days
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Delafloxacin
Number of subjects: 850

Group type: COMPARATOR
Intervention: Vancomycin + aztreonam
Number of subjects: 850
Study: 28460260

Group type: EXPERIMENTAL
Intervention: FDG PET/CT
Number of subjects: 394

Group type: COMPARATOR
Intervention: Limited screening
Number of subjects: 394
Study: 26775477

Group type: EXPERIMENTAL
Intervention: Blood Activating Wind Dissipating Acupuncture (BAWDA) for 6 weeks (30 sessions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Blood Activating Wind Dissipating Acupuncture (BAWDA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (lifestyle intervention only)
Number of subjects: 60
Study: 23749688

Group type: EXPERIMENTAL
Intervention: 8-week supervised aerobic exercise training (twice weekly)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 43
Study: 20970119

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 706

Group type: COMPARATOR
Intervention: Saline (control for mice)
Number of subjects: 706
Study: 19930864

Group type: EXPERIMENTAL
Intervention: Screening and brief intervention (SBI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motivation, adequate knowledge and skills, record keeping (actions that can be changed by GPs themselves)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community action (government intervention)
Number of subjects: 0
Study: 16862472

Group type: EXPERIMENTAL
Intervention: Single dose of intravenous cephalothin 2 g, intraoperatively
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Standard antibiotics scheme followed at this center (penicillin)
Number of subjects: 600

Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 600
Study: 14660044

Group type: EXPERIMENTAL
Intervention: Adult mesenchymal stem cells (MSC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First trimester fetal MSC
Number of subjects: 0
Study: 10858827

Group type: EXPERIMENTAL
Intervention: Mucin-based artificial saliva (Saliva Orthana)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-tack, sugar-free chewing gum (Freedent)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 9009151

Group type: EXPERIMENTAL
Intervention: Nicotine patch therapy (group Q)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nicotine patch therapy (group R)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo patch (control group)
Number of subjects: 50
Study: 8251901

Group type: EXPERIMENTAL
Intervention: Splenic irradiation (SI+)
Number of subjects: 229

Group type: COMPARATOR
Intervention: No splenic irradiation (SI-)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Both groups (SI+ and SI-)
Number of subjects: 229
Study: 2871185

Group type: EXPERIMENTAL
Intervention: Ethanol consumption prior to cognitive task
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ethanol consumption prior to electronic game
Number of subjects: 20

Group type: COMPARATOR
Intervention: No ethanol consumption (control)
Number of subjects: 20
Study: 30445895

Group type: EXPERIMENTAL
Intervention: Antipsychotics
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Anxiolytics
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Higher antipsychotic dosage at discharge
Number of subjects: 175
Study: 26840944

Group type: EXPERIMENTAL
Intervention: Billroth I reconstruction
Number of subjects: 122

Group type: COMPARATOR
Intervention: Roux-en-Y reconstruction
Number of subjects: 122
Study: 24885735

Group type: EXPERIMENTAL
Intervention: 15-minute rope skipping activity inserted in four consecutive PE lessons
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 24
Study: 22016263

Group type: EXPERIMENTAL
Intervention: Applied tension during the pre‐donation wait period
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Applied tension during the blood draw
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Applied tension during both pre‐donation wait period and blood draw
Number of subjects: 282

Group type: COMPARATOR
Intervention: No applied tension at all (control group)
Number of subjects: 282
Study: 20347286

Group type: EXPERIMENTAL
Intervention: Traditional exercise therapy (TET) program
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Behavioral lifestyle activity program (LAP)
Number of subjects: 176
Study: 18360186

Group type: EXPERIMENTAL
Intervention: Modular group (n = 72)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (n = 72)
Number of subjects: 144
Study: 15814481

Group type: EXPERIMENTAL
Intervention: Abbreviated Portland Digit Recognition Test (PDRT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard Portland Digit Recognition Test (PDRT)
Number of subjects: 200
Study: 11919489

Group type: EXPERIMENTAL
Intervention: MSL-109
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 10342080

Group type: COMPARATOR
Intervention: Methotrexate alone (50 mg/m2 intramuscularly)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Methotrexate followed by misoprostol (800 micrograms vaginally)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 358
Study: 8620703

Group type: COMPARATOR
Intervention: Oral prednisolone, 50 mg (PRED)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Inhaled placebo (PL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Inhaled fluticasone propionate, 1,000 micrograms (F1000)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Inhaled fluticasone propionate, 2,000 micrograms (F2000)
Number of subjects: 10
Study: 1835830

Group type: EXPERIMENTAL
Intervention: Sodium chloride solution
Number of subjects: 77

Group type: COMPARATOR
Intervention: Dilute heparin solution
Number of subjects: 77
Study: 7343723

Group type: EXPERIMENTAL
Intervention: guanethidine/epinephrine combination
Number of subjects: 50

Group type: COMPARATOR
Intervention: timolol maleate/epinephrine
Number of subjects: 50
Study: 31526108

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normal Sleep (NS)
Number of subjects: 13
Study: 28463672

Group type: EXPERIMENTAL
Intervention: Ligation of the inferior mesenteric artery distal to the left colic artery (low ligation)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Complete preservation of the inferior mesenteric artery (IMA preservation)
Number of subjects: 66
Study: 26359076

Group type: EXPERIMENTAL
Intervention: Continuous femoral block (CFNB)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Patient controlled intravenous analgesia (PCIA)
Number of subjects: 280
Study: 23426616

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (100 mg/kg/d for 4 weeks)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Healthy control subjects (11 untrained, age- and sex-matched)
Number of subjects: 4
Study: 21163806

Group type: EXPERIMENTAL
Intervention: Piecewise linear approach to model smoking and gene-by-smoking interactions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total pack-years approach
Number of subjects: 0
Study: 19276620

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: antioxidants
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: both supplements (antioxidants and n-3 fatty acids)
Number of subjects: 72

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study: 17327261

Group type: EXPERIMENTAL
Intervention: loveLife national HIV prevention programme
Number of subjects: 0
Study: 15310346

Group type: EXPERIMENTAL
Intervention: Propofol sedation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midazolam sedation
Number of subjects: 0
Study: 11782332

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil with epinephrine (100 microg/mL)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Epidural sufentanil without epinephrine (saline)
Number of subjects: 43
Study: 9821033

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Prior contralateral stroke
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Prior TIA
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Prior amaurosis fugax
Number of subjects: 1314

Group type: COMPARATOR
Intervention: No prior symptoms
Number of subjects: 1314
Study: 7703623

Group type: EXPERIMENTAL
Intervention: MFP-calcium-treated group (sodium monofluorophosphate 26 mg/day of fluoride + 1000 mg of calcium)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (calcium alone)
Number of subjects: 48
Study: 2667315

Group type: EXPERIMENTAL
Intervention: Raw manihot starch
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cooked starches
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cooked mung bean noodles
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: In vitro starch hydrolysis at 30 min
Number of subjects: 18
Study: 1064725

Group type: EXPERIMENTAL
Intervention: Oxygel application and tooth brushing twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31392401

Group type: EXPERIMENTAL
Intervention: 28.2-μg twice-weekly teriparatide
Number of subjects: 553

Group type: COMPARATOR
Intervention: 56.5-μg once-weekly teriparatide
Number of subjects: 553
Study: 28290296

Group type: EXPERIMENTAL
Intervention: Sourdough breads made with organic flour
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sourdough breads made with einkorn flour
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All sourdough breads
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Einkorn bread
Number of subjects: 16
Study: 25482330

Group type: EXPERIMENTAL
Intervention: Simeprevir (150 mg once a day) plus peginterferon alfa‐2a and ribavirin
Number of subjects: 763

Group type: COMPARATOR
Intervention: Telaprevir (750 mg three times a day) plus peginterferon alfa‐2a and ribavirin
Number of subjects: 763

Group type: EXPERIMENTAL
Intervention: Simeprevir
Number of subjects: 763

Group type: COMPARATOR
Intervention: Telaprevir
Number of subjects: 763
Study: 23507683

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D supplementation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D supplementation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 500 IU vitamin D supplementation
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 21689848

Group type: EXPERIMENTAL
Intervention: Behavioural change, moderate intensity physical activity intervention (n=16)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Contact Control group (n=17)
Number of subjects: 33
Study: 20137594

Group type: EXPERIMENTAL
Intervention: Xue Bijing injection, 100 ml intravenous once a day for 7 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Normal saline as placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Xue Bijing injection
Number of subjects: 52
Study: 16960242

Group type: EXPERIMENTAL
Intervention: Speed-of-processing intervention
Number of subjects: 2147

Group type: EXPERIMENTAL
Intervention: Memory intervention
Number of subjects: 2147

Group type: EXPERIMENTAL
Intervention: Reasoning intervention
Number of subjects: 2147

Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 2147
Study: 15228371

Group type: EXPERIMENTAL
Intervention: Preferred biologic therapy recommended for prior-authorization (PA) criteria
Number of subjects: 0

Group type: COMPARATOR
Intervention: Biologic agent with marginal incremental clinical benefit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biologic agent with increased efficacy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flexible PA criteria for drug coverage
Number of subjects: 0
Study: 11703235

Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine with Hartmann's solution
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (Hartmann's solution without bupivacaine)
Number of subjects: 56
Study: 9130221

Group type: EXPERIMENTAL
Intervention: 3% mepivicaine (1.0 ml)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 44
Study: 8190448

Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam (3 g every 6 hours)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Cefoxitin (2 g every 6 hours) plus doxycycline (100 mg every 12 hours)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Clindamycin (900 mg every 8 hours) plus gentamicin (1.5 mg/kg every 8 hours)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam
Number of subjects: 415

Group type: COMPARATOR
Intervention: Cefoxitin plus doxycycline
Number of subjects: 415

Group type: COMPARATOR
Intervention: Clindamycin plus gentamicin
Number of subjects: 415
Study: 3370078

Group type: EXPERIMENTAL
Intervention: Piracetam 1600 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Piracetam 2400 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31782495

Group type: EXPERIMENTAL
Intervention: Knowledge about dengue and its severity
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Awareness of types of mosquitoes causing dengue
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Factors associated with willingness to pay (WTP) for mosquito control
Number of subjects: 330
Study: 30460634

Group type: EXPERIMENTAL
Intervention: 5-Azacytidine (5-AZA) 10 mg infusions, 12 consecutive weekly infusions planned
Number of subjects: 6
Study: 27858681

Group type: EXPERIMENTAL
Intervention: Osteopathic manual therapy (OMT) and exercise methods
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Visceral osteopathic manual therapy (vOMT)
Number of subjects: 39
Study: 25977995

Group type: EXPERIMENTAL
Intervention: Umbilical cord blood (UCB)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 23908160

Group type: EXPERIMENTAL
Intervention: 2.5% crude glycerin
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 5% crude glycerin
Number of subjects: 240

Group type: COMPARATOR
Intervention: 0% crude glycerin (control)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Crude glycerin (0, 2.5, 5%)
Number of subjects: 240
Study: 22188876

Group type: EXPERIMENTAL
Intervention: Tailored training in applying the guidelines for depression (Intervention Group, n = 21)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alternative programme (Control Group, n = 19)
Number of subjects: 40
Study: 17909808

Group type: EXPERIMENTAL
Intervention: 250 mg granular formulation of gefitinib
Number of subjects: 18

Group type: COMPARATOR
Intervention: 250 mg tablet of gefitinib
Number of subjects: 18
Study: 16552473

Group type: EXPERIMENTAL
Intervention: nifedipine GITS
Number of subjects: 7665

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7665
Study: 12806325

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (hybrid composites)
Number of subjects: 8
Study: 10918945

Group type: EXPERIMENTAL
Intervention: Calcium antagonist (benidipine)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitor (trandolapril)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normotensive subjects (control group)
Number of subjects: 15
Study: 8855458

Group type: EXPERIMENTAL
Intervention: Local anesthetic blocks (C2-C3 zygapophysial joint)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo-controlled local anesthetic blocks
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Overall prevalence assessment
Number of subjects: 68
Study: 1509527

Group type: EXPERIMENTAL
Intervention: Low birth weight formula
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 22
Study: 6139191

Group type: EXPERIMENTAL
Intervention: Combination of hydroxyzine (10 mg qds) and cimetidine (400 mg qds)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Other antihistamine regimes
Number of subjects: 50
Study: 31512201

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM)
Number of subjects: 16007

Group type: EXPERIMENTAL
Intervention: Prediabetes
Number of subjects: 16007

Group type: COMPARATOR
Intervention: No Diabetes
Number of subjects: 16007
Study: 29449140

Group type: EXPERIMENTAL
Intervention: Multicomponent self-management intervention (MCI)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 102
Study: 26618243

Group type: EXPERIMENTAL
Intervention: PHiD-CV/dPly/PhtD-30
Number of subjects: 120

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 120
Study: 23627422

Group type: EXPERIMENTAL
Intervention: High mutability induction
Number of subjects: 688

Group type: COMPARATOR
Intervention: Low mutability induction
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Feedback on uniqueness of values
Number of subjects: 688

Group type: COMPARATOR
Intervention: Feedback on similarity of values
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Feedback on uniqueness of traits
Number of subjects: 688

Group type: COMPARATOR
Intervention: Feedback on similarity of traits
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Self-reported values and traits
Number of subjects: 688
Study: 22406278

Group type: EXPERIMENTAL
Intervention: ProQuad(®) (MMRV vaccine) Dose 1 at 9 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ProQuad(®) (MMRV vaccine) Dose 1 at 11 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ProQuad(®) (MMRV vaccine) Dose 1 at 12 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ProQuad(®) (MMRV vaccine) Dose 1 at 9 months, 11 months, or 12 months
Number of subjects: 0
Study: 20162300

Group type: EXPERIMENTAL
Intervention: Fast dynamic stretching at 100 b/min (FDS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Slow dynamic stretching at 50 b/min (SDS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No stretching (NS)
Number of subjects: 24
Study: 17916667

Group type: EXPERIMENTAL
Intervention: 6% glucose beverage (1.00 g carbohydrate/kg body mass)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo beverage (NG)
Number of subjects: 15
Study: 11731997

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 9405898

Group type: EXPERIMENTAL
Intervention: Palmitic acid-rich diet
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Stearic acid-rich diet
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich diet
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 15
Study: 8476333

Group type: EXPERIMENTAL
Intervention: Advance information suggesting sexual content
Number of subjects: 269

Group type: COMPARATOR
Intervention: Advance information suggesting nonsexual content
Number of subjects: 269
Study: 3629428

Group type: EXPERIMENTAL
Intervention: Annual chest radiographs
Number of subjects: 10040

Group type: EXPERIMENTAL
Intervention: Sputum cytologic examinations (4-monthly)
Number of subjects: 10040

Group type: EXPERIMENTAL
Intervention: Chest radiographs
Number of subjects: 10040

Group type: COMPARATOR
Intervention: Sputum cytology
Number of subjects: 10040

Group type: COMPARATOR
Intervention: Overall survival
Number of subjects: 10040
Study: 29577522

Group type: EXPERIMENTAL
Intervention: Maastricht Acute Stress Task (MAST)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-stressful version of the task
Number of subjects: 42
Study: 28961836

Group type: EXPERIMENTAL
Intervention: CAP45 (RT 45 Gy + capecitabine)
Number of subjects: 598

Group type: COMPARATOR
Intervention: CAPOX50 (RT 50 Gy + capecitabine and oxaliplatin)
Number of subjects: 598
Study: 25976690

Group type: EXPERIMENTAL
Intervention: Arthrocentesis plus platelet-rich plasma (PRP) injection and then 4 consecutive PRP injections
Number of subjects: 30

Group type: COMPARATOR
Intervention: Arthrocentesis alone (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Arthrocentesis plus PRP
Number of subjects: 30
Study: 22874653

Group type: EXPERIMENTAL
Intervention: Supplementary snacks at school
Number of subjects: 182
Study: 20833556

Group type: EXPERIMENTAL
Intervention: Group B (intercostal muscle dissection technique)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group A (intercostal nerve compression technique)
Number of subjects: 60
Study: 18358590

Group type: EXPERIMENTAL
Intervention: G-CSF treatment
Number of subjects: 0
Study: 16556754

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave treatment (1500 impulses at 16 kV in a single session)
Number of subjects: 149
Study: 14505915

Group type: EXPERIMENTAL
Intervention: Intranasal virosome vaccine adjuvanted with heat-labile toxin (HLT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Intranasal vaccine without HLT
Number of subjects: 88

Group type: COMPARATOR
Intervention: Intramuscular vaccine
Number of subjects: 88
Study: 10929963

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (non-tamoxifen users)
Number of subjects: 67
Study: 8738052

Group type: EXPERIMENTAL
Intervention: Casodex 50 mg monotherapy
Number of subjects: 376

Group type: COMPARATOR
Intervention: Orchidectomy
Number of subjects: 376
Study: 1582291

Group type: EXPERIMENTAL
Intervention: Astemizole (10 mg/ml)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30730770

Group type: EXPERIMENTAL
Intervention: Staying Strong With Schools (SSWS)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Educational pamphlet waitlist control
Number of subjects: 56
Study: 29249532

Group type: EXPERIMENTAL
Intervention: n-3 PUFA (0.945 g/day, 64% ALA, 21% EPA, 16% DHA)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: n-3 PUFA
Number of subjects: 27
Study: 26347527

Group type: EXPERIMENTAL
Intervention: Senior trainees
Number of subjects: 32

Group type: COMPARATOR
Intervention: Junior trainees
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Overall assessment
Number of subjects: 32